Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06288711 · ClinicalTrials.gov registry record · NA

Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD

A NA study of Opioid Use Disorder and Posttraumatic Stress Disorder, sponsored by University of Vermont.

Recruiting
Registry status
NA
Development phase
135
Enrollment target
1
Study location

NCT06288711 is a NA study of Opioid Use Disorder and Posttraumatic Stress Disorder that is actively recruiting participants, run by University of Vermont. The registered enrollment target is 135 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06288711, a NA study of Opioid Use Disorder and Posttraumatic Stress Disorder, is actively recruiting participants, sponsored by University of Vermont.

RECRUITING
Registry status
NA
Development phase
135 participants
Enrollment target
1
Study location

Study Summary

Among individuals with opioid use disorder (OUD), posttraumatic stress disorder (PTSD) presents a significant clinical challenge. The prevalence of PTSD is substantially higher in individuals with OUD than in the general population, with nearly 90% reporting lifetime trauma exposure and 33% meeting diagnostic criteria for PTSD. The primary objective of this study is to evaluate the efficacy of a novel telemedicine-delivered prolonged exposure therapy protocol for improving PE attendance and reducing PTSD symptom severity in individuals with concurrent PTSD and OUD.

Conditions Studied

Opioid Use Disorder Posttraumatic Stress Disorder

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Prolonged exposure therapy
  • BEHAVIORAL Financial incentives

Study Locations (1)

Vermont

  • University of Vemont - Burlington

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2024-06-03
Est. Completion 2027-11-30
Phase NA

Sponsor

University of Vermont

162 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06288711

The ClinicalTrials.gov registry entry for NCT06288711 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual is the first listed.

NCT06288711 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.

Frequently Asked Questions

What is clinical trial NCT06288711 about?

NCT06288711 is a clinical study titled "Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD". Among individuals with opioid use disorder (OUD), posttraumatic stress disorder (PTSD) presents a significant clinical challenge. The prevalence of PTSD is substantially higher in individuals with OUD than in the general population, with nearly 90% reporting lifetime trauma exposure and 33% meeting ...

What is the current status of trial NCT06288711?

This trial is currently recruiting. It is a NA study. The enrollment target is 135 participants. The study started on 2024-06-03. Estimated completion is 2027-11-30.

What conditions does trial NCT06288711 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT06288711?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Prolonged exposure therapy (BEHAVIORAL), Financial incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT06288711?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06288711 being conducted?

This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Posttraumatic Stress Disorder

All registered trials for this condition

Vermont

All trials with a study site in Vermont

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.